Northern Trust
CAMP icon

Northern Trust’s CAMP4 Therapeutics CAMP Stock Holding History

Northern Trust’s Portfolio CAMP Stock Details CAMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09M Buy
248,673
+178,007
+252% +$767K ﹤0.01% 3431
2026
Q1 		$312K Sell
70,666
-3,843
-5% -$18.2K ﹤0.01% 3787
2025
Q4 		$457K Buy
74,509
+59,894
+410% +$255K ﹤0.01% 3687
2025
Q3 		$43.8K Hold
14,615
– – ﹤0.01% 4296
2025
Q2 		$21.2K Sell
14,615
-42,324
-74% -$84.2K ﹤0.01% 4329
2025
Q1 		$228K Buy
56,939
+5,079
+10% +$24.6K ﹤0.01% 3901
2024
Q4 		$271K Buy
+51,860
New +$426K ﹤0.01% 3878

Other funds holding CAMP

Jupiter Topco
Jupiter Topco New York $245B AUM
5AM Venture Management
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vivo Capital
Vivo Capital Palo Alto, California $909M AUM 385.65% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
AH Capital Management
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Trails Edge Capital Partners
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Northern Trust's CAMP Position: Q2 2026 in Review

Northern Trust increased its CAMP4 Therapeutics (CAMP) stake by 252% in Q2 2026, buying an estimated $767K and bringing the position to 248,673 shares worth $1.09M. The position accounts for ﹤0.01% of the portfolio, ranked #3431.

Northern Trust first reported a position in CAMP in Q4 2024 and has held it in 7 quarters since. 61 funds tracked by Wall St. Rank hold CAMP as of Q2 2026.

  • Northern Trust held 248,673 shares of CAMP4 Therapeutics worth $1.09M as of Q2 2026.
  • Northern Trust bought 178,007 CAMP4 Therapeutics shares in Q2 2026, an estimated $767K.
  • CAMP4 Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #3431 holding.
  • Northern Trust first reported a position in CAMP4 Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 61 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.